The FDA placed BPC-157 on import alert, making it legally ineligible as a dietary supplement ingredient in the U.S
As a GLP-1 receptor agonist, it works by mimicking a hormone your body naturally produces to regulate blood sugar and appetite
Lead author Dr Ilaria Costantini (UCL Psychiatry) said: Binge eating disorder, where people regularly eat an excessive amount of food while feeling they have lost control, is common and highly impairing, affecting over 17 million people worldwide
Wegovy (semaglutide) operates differently as a GLP-1 receptor agonist
McMurray JJV, Solomon SD, Inzucchi SE, Kber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Blohlvek J, Bhm M, Chiang C-E, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukt A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, OMeara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjstrand M, Langkilde A-M